The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Applied DNA Sciences Inc

Nasdaq: APDN
Last

(U.S.) $3.47

Today's change-0.05 -1.42%
Updated September 2 2:05 PM -4GMT. Delayed by at least 15 minutes.
 

Applied DNA Sciences Inc

Nasdaq: APDN
Last

(U.S.) $3.47

Today's change-0.05 -1.42%
Updated September 2 2:05 PM -4GMT. Delayed by at least 15 minutes.

Reversal following new 50-day high

Applied DNA Sciences Inc is lower today, dropping (U.S.)$0.05 or 1.42% to (U.S.)$3.47 after setting a new 50-day high. Over the last five days, shares have gained 8.44% and 20.07% year to date. Shares have underperformed the S&P 500 by 42.62% during the last year.

Key company metrics

  • Open(U.S.) $3.51
  • Previous close(U.S.) $3.52
  • High(U.S.) $3.60
  • Low(U.S.) $3.36
  • Bid / Ask(U.S.) $3.42 / (U.S.) $3.49
  • YTD % change+20.07%
  • Volume47,306
  • Average volume (10-day)89,668
  • Average volume (1-month)84,219
  • Average volume (3-month)88,137
  • 52-week range(U.S.) $2.02 to (U.S.) $7.70
  • Beta1.66
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.84
Updated September 2 2:05 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-237.77%

Applied DNA Sciences Inc has a net profit margin of -237.77%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.23%Sector:Basic MaterialsIndustry:Chemicals - Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue2211
Total other revenue--------
Total revenue2211
Gross profit--------
Total cost of revenue--------
Total operating expense4353
Selling / general / administrative4353
Research & development0000
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-2-2-4-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-2-8-2
Income after tax-2-2-8-2
Income tax, total00--0
Net income-2-2-8-2
Total adjustments to net income--------
Net income before extra. items-2-2-8-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-2-8-2
Inc. avail. to common incl. extra. items-2-2-8-2
Diluted net income-2-2-8-2
Dilution adjustment----00
Diluted weighted average shares21171514
Diluted EPS excluding extraordinary itemsvalue per share-0.08-0.11-0.51-0.15
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.08-0.11-0.51-0.15